Christophe Legendre

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

Christophe Legendre, Christoph Licht, Petra Muus et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

Alexandre Loupy, Carmen Lefaucheur, Déwi Vernerey et al. · New England Journal of Medicine · 2013 · 833 citations · Full text

Life Sciences, Immunology, Surgery +17

Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation

David C. Lowance, Hans‐H. Neumayer, Christophe Legendre et al. · New England Journal of Medicine · 1999 · 716 citations · Full text

Medicine, Infectious Diseases, Nephrology +17

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology

Alexandre Loupy, Mark Haas, Kim Solez et al. · American Journal of Transplantation · 2016 · 624 citations · Full text

Life Sciences, Immunology, Pathology +17

Targeted therapy in patients with PIK3CA-related overgrowth syndrome

Quitterie Venot, Thomas Blanc, Laureline Berteloot et al. · Nature · 2018 · 575 citations · Full text

Medicine, Molecular Medicine, Oncology +12